Cabot Corporation logo

Cabot Corporation (CBT)

Market Closed
16 Oct, 08:00 PM
NYSE NYSE
$
74. 29
-1.19
-1.5766%
$
3.87B Market Cap
12.14 P/E Ratio
1.72% Div Yield
317,287 Volume
6.64 Eps
$ 75.48
Previous Close
Add Transaction
Day Range
73.99 76.65
Year Range
58.33 94.53
Want to track CBT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cabot Q1 Earnings Beat Estimates, Sales Down Y/Y on Lower Volumes

Cabot Q1 Earnings Beat Estimates, Sales Down Y/Y on Lower Volumes

CBT's fiscal Q1 earnings beat estimates despite lower sales, as Reinforcement Materials demand stayed weak and full-year EPS guidance was narrowed.

Zacks | 8 months ago
Cabot (CBT) Q1 Earnings Surpass Estimates

Cabot (CBT) Q1 Earnings Surpass Estimates

Cabot (CBT) came out with quarterly earnings of $1.53 per share, beating the Zacks Consensus Estimate of $1.4 per share. This compares to earnings of $1.76 per share a year ago.

Zacks | 8 months ago
CBT Signs Agreement to Supply EV Battery Materials to PowerCo

CBT Signs Agreement to Supply EV Battery Materials to PowerCo

Cabot inks a multi-year deal with PowerCo to supply conductive battery materials, strengthening its push into Europe's fast-growing EV battery market.

Zacks | 9 months ago
Cabot (CBT) Up 4.4% Since Last Earnings Report: Can It Continue?

Cabot (CBT) Up 4.4% Since Last Earnings Report: Can It Continue?

Cabot (CBT) reported earnings 30 days ago. What's next for the stock?

Zacks | 10 months ago
Is the Options Market Predicting a Spike in Cabot Stock?

Is the Options Market Predicting a Spike in Cabot Stock?

Investors need to pay close attention to Cabot stock based on the movements in the options market lately.

Zacks | 10 months ago
Is It Time To Buy Cabot Stock?

Is It Time To Buy Cabot Stock?

Cabot (CBT) hasn't been in the spotlight lately, but its current setup may warrant a closer look. The specialty chemicals company has quietly built a strong financial base while its stock remains meaningfully discounted from recent highs.

Forbes | 11 months ago
Cabot's Q4 Earnings and Sales Miss Estimates, Decline Y/Y

Cabot's Q4 Earnings and Sales Miss Estimates, Decline Y/Y

CBT's Q4 earnings miss estimates as weaker demand and volumes weighed on sales.

Zacks | 11 months ago
Cabot: The Decline Now Sees Valuation Making Sense (Rating Upgrade)

Cabot: The Decline Now Sees Valuation Making Sense (Rating Upgrade)

Cabot Corporation is a fundamentally strong, conservatively managed chemical company trading at a significant discount to fair value. CBT offers high single-digit growth, a well-covered dividend, and is positioned for long-term upside despite recent market-driven declines. Recent results show resilience in key segments and strategic expansion, with risks mainly tied to macro volatility and market sentiment.

Seekingalpha | 11 months ago
CBT Boosts North American Capacity of Circular Reinforcing Carbons

CBT Boosts North American Capacity of Circular Reinforcing Carbons

Cabot boosts its North American capacity to produce sustainable circular reinforcing carbons, advancing its EVOLVE platform and regional manufacturing strategy.

Zacks | 1 year ago
Why Is Cabot (CBT) Up 0.9% Since Last Earnings Report?

Why Is Cabot (CBT) Up 0.9% Since Last Earnings Report?

Cabot (CBT) reported earnings 30 days ago. What's next for the stock?

Zacks | 1 year ago
Cabot's Earnings Top Estimates in Q3, Sales Miss on Lower Volumes

Cabot's Earnings Top Estimates in Q3, Sales Miss on Lower Volumes

Cabot beats Q3 profit forecasts despite lower volumes, with strong cash flow and reaffirmed 2025 earnings guidance.

Zacks | 1 year ago
Cabot Corporation (CBT) Q3 2025 Earnings Call Transcript

Cabot Corporation (CBT) Q3 2025 Earnings Call Transcript

Cabot Corporation (NYSE:CBT ) Q3 2025 Earnings Conference Call August 5, 2025 8:00 AM ET Company Participants Erica J. McLaughlin - Executive VP, CFO & Head of Corporate Strategy Sean D.

Seekingalpha | 1 year ago
Loading...
Load More